Filter
69
Filtered Results: 69
Text search:
Sputnik
V
Featured
Recommendations
4
New Publications
19
Language
Document type
Studies & Reports
16
Guidelines
14
Fact sheets
14
No document type
9
Resource Platforms
5
Manuals
4
Situation Updates
3
Strategic & Response Plan
3
Infographics
1
Countries / Regions
Argentina
10
Ukraine
6
Chile
4
Paraguay
4
Russia
4
Africa
3
Latin America and the Carribbean
3
Germany
3
Brazil
3
Syria
2
Western and Central Europe
2
India
2
Kenya
1
Ghana
1
Congo-Brazzaville
1
Mozambique
1
Guinea-Bissau
1
West and Central Africa
1
South–East Asia Region
1
Eastern Europe and Central Asia
1
Belarus
1
East and Southern Africa
1
Angola
1
Authors & Publishers
Publication Years
Category
COVID-19
40
Guidelines
9
Studies & Reports
7
Women & Child Health
3
Information, Education and Communication (IEC)
2
Hepatitis
1
Pediatrics
1
Policies
1
Humanitarian Crisis
1
Pharmacy & Technologies
1
Toolboxes
Country specific documents
26
Immunization Guidelines
5
TB & Drug Abuse
4
Global Impact: Socio-economic, health services, TB & HIV
3
Communication Material
3
Vaccine Hesitancy & Myths
3
Biontech/Pfizer Comirnaty
3
Johnson & Johnson
3
Sputnik V
3
Information Refugees Ukraine
3
Poster & Infographics
2
For General Public & Community
2
Scientific & Research Studies
2
Country-specific Platforms
2
Dashboards & Resource Platforms
2
Fair Allocation & Ethical Aspects
2
Moderna
2
Vaxzevria (Astra Zeneca)
2
Estonia
2
Booster Doses
2
Integration
1
Vaccination
1
Ukraine
1
Pediatrics
1
Germany
1
Clinical Guidelines
1
General
1
COVID-19
1
For Parents & Children
1
For Pregnant Women
1
Dashboards & Maps
1
Paediatrics
1
HIV and COVID-19
1
Hospital Readiness/Essential Health Services
1
Vaccination & Strategy
1
Access & Strategy
1
COVID-19 Vaccination
1
Research & Pipeline
1
Inactivated COVID-19 Vaccines
1
Essential Medicines
1
Prices and Patents
1
Situation Reports & Updates
1
Information, Resources & Websites
1
COVID-19
1
Global Overview
1
Situation Reports & Updates
1
Human Rights & the Right to Health
1
Miscellaneous
1
Public Health Administration
1
Orientation Guides
1
Refugees & Migrants
1
Volunteers
1
Country Specific Information
1
Reports & Studies
1
Eastern Europe and central Asia
1
Меры по борьбе с эпидемией
Текущая актуализация мер по борьбе с КОВИД-19 в СНГ
Information bulletins on measures to combat coronavirus in CIS countries
AstraZeneca-SKBio in South Korea and Serum Institute of India
African Union and the Africa Centers for Disease Control and Prevention’s Africa Regulatory Taskforce has endorsed the Emergency Used Authorization for Janssen COVID-19 Vaccine
10 March 2021
Este plano apresenta diretrizes gerais para a Campanha Nacional de Vacinação contra a Covid-19, de forma que especificidades e alterações de cenários conforme disponibilidade de vacinas serão informadas e divulgadas por meio de Informes Técnicos da Campanha Nacional de Vacinação, divulgados...
Many critical questions remain about the effectiveness of COVID-19 vaccines in real-world settings. These questions can only be answered in post-introduction vaccine effectiveness studies.This guidance document outlines an approach to leverage existing surveillance systems for Severe Acute Respirato...
Recommendations for the adaptation of Emergency Medical Teams (EMTs) at temporary sites for COVID-19 vaccination. Draft Version 2.3, November 2021
Additional dose of the primary vaccination against COVID-19: Technical Guidelines
Vaccinator's Manual. Pfizer-BioNTech Comirnaty Vaccine
Vaccinator's Manual. CONVIDECIA Vaccine
Vaccinator's Manual SINOPHARM Vaccine - 28 FEBRUARY 2021
Emergency medical teams (EMTs) play an important role in strengthening health service networks in terms of their strategies and tactics for planning mass vaccination programs, especially in remote or under-resourced areas or those overwhelmed by COVID-19. EMTs experience deploying in remote areas an...
The aim of this article is to identify the elements behind the country’s successful COVID-19 rollout as well as lessons and chal lenges derived from this process. The analysis is relevant to many countries today—as they keep searching for strategies to cope with the second year of the COVID-19 p...
Campaña Nacional de Vacunación contra la COVID-19
La dosis de refuerzo está indicada una vez transcurridos los 4 meses (120 días) de la última dosis del esquema inicial y será con vacuna de plataforma ARNm: Pfizer-BioNTech pediátrica a partir de los 5 años o Moderna para uso pediátrico a partir de los 6 años.
La evidencia disponible a nivel internacional sobre el uso de un segundo refuerzo muestra una mayor duración de la respuesta inmune y una disminución de la internación y la mortalidad por COVID 19 en la población de adultos mayores y huéspedes inmunocomprometidos. Por otra parte, el personal de...
Los datos preliminares de eficacia se infirieron mediante un enfoque de “inmunogenicidad puente”, en el que los títulos neutralizantes obtenidos después de la vacuna en niños y niñas de 5 a 11 años se compararon con los títulos obtenidos en adolescentes de 16 a 25 años (en quienes se hab...
El siguiente manual se continuará actualizando, de ser necesario, a medida que se disponga de nueva información.
